Drug interactions
Deferasirox + Selexipag
Severity: Moderate
Deferasirox and Selexipag: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Selexipag is converted to its active metabolite partly through CYP2C8, and deferasirox inhibits CYP2C8 moderately. Exposure to the active metabolite may increase, leading to more prostacyclin-related adverse effects such as headache, diarrhea and jaw pain.
What this interaction means in plain words
Deferasirox and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Deferasirox belongs to Miscellaneous; Selexipag belongs to Cardiovascular.
Why it happens
Deferasirox inhibits CYP2C8, reducing metabolism of selexipag and its active metabolite.
What to do
Reduce selexipag to once-daily dosing while deferasirox is used. Watch for adverse effects and return to the usual schedule if deferasirox is stopped.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Selexipag, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Deferasirox
Other interactions of Selexipag
- Gemfibrozil + Selexipag Contraindicated
- Abiraterone + Selexipag Moderate
- Apalutamide + Selexipag Moderate
- Carbamazepine + Selexipag Moderate
- Clopidogrel + Selexipag Moderate
- Cyclosporin + Selexipag Moderate
Frequently asked questions
Can I take Deferasirox with Selexipag?
MediHelp rates the interaction as moderate. Deferasirox and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Selexipag is converted to its active metabolite partly through CYP2C8, and deferasirox inhibits CYP2C8 moderately. Exposure to the active metabolite may increase, leading to more prostacyclin-related adverse effects such as headache, diarrhea and jaw pain.
How serious is the interaction between Deferasirox and Selexipag?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce selexipag to once-daily dosing while deferasirox is used. Watch for adverse effects and return to the usual schedule if deferasirox is stopped.
What other medicines interact with Deferasirox?
MediHelp also lists interactions of Deferasirox with, for example, Acetylsalicylic acid, Alosetron, Aluminum hydroxide. The full list is on the Deferasirox page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
